fbpx
Medical Innovation Exchange

After phase 3 fail, Biogen posts 12-month data cut to make case for ALS prospect

https://www.fiercebiotech.com/biotech/after-phase-3-fail-biogen-posts-12-month-data-make-case-als-prospect

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.